Texas Capital Bancshares Inc Pfizer Inc Transaction History

Texas Capital Bancshares Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $179,650 - $234,513	4,303 New	4,303 $220,000
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $196,356 - $232,817	4,220 New	4,220 $221,000
Q3 2019 Oct 28, 2019	SELL	$32.49 - $42.13 $247,963 - $321,536	-7,632 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$36.98 - $41.52 $94,705 - $106,332	2,561 Added 50.5%	7,632 $331,000
Q3 2018 Oct 18, 2018	BUY	$34.47 - $41.81 $174,797 - $212,018	5,071 New	5,071 $223,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Texas Capital Bancshares Inc, based on Form 13F filings with the SEC.

Stay updated on Texas Capital Bancshares Inc with notifications on news.